SL
Sean Laaman Morgan Stanley Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
23
Avg Return
Past Year
Past Year
5.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
78.3%
Neutral
21.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Initiated
| $32 |
243%
upside
| 1 | -13% |
0
%
| 2 Mar ‘26 3 months ago |
|
|
|
Overweight
Maintained
| $98 |
44%
upside
| 2 | -1.5% |
0
%
| 25 Feb ‘26 3 months ago |
|
|
|
Equal-Weight
Maintained
| $49 |
8%
downside
| 6 | +2% |
0
%
| 2 Feb ‘26 4 months ago |
|
|
|
Equal-Weight
Downgraded
| $204 |
19%
downside
| 4 | +18% |
0
%
| 8 Jan ‘26 5 months ago |
|
|
|
Equal-Weight
Maintained
| $12 |
130%
upside
| 2 | – |
–
| 18 Dec ‘25 6 months ago |
|
|
|
Overweight
Initiated
| $20 |
159%
upside
| 1 | -21% |
0
%
| 5 Dec ‘25 6 months ago |
|
|
|
Overweight
Initiated
| $34 |
22%
upside
| 1 | +51% |
0
%
| 21 Nov ‘25 6 months ago |
|
|
|
Overweight
Maintained
| $115 |
64%
upside
| 3 | +8.7% |
0
%
| 30 Oct ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $304 |
58%
upside
| 1 | -15% |
0
%
| 21 Oct ‘25 7 months ago |
|
|
|
Overweight
Maintained
| $383 |
43%
upside
| 2 | +7.7% |
0
%
| 20 Oct ‘25 7 months ago |
|